From CC presentation
Dr. Pourhassan: three matters - BLA, Cancer, Covid-19
Four reasons or pushbacks against getting BLA completed with submission... The BLA IS submitted!
Cancer studies: 12 paitents ended up having 0 CTC after treatment... while most could not give blood samples in the last few months because of covid-19... my own family member has seen great results Her doctor never imagined her situation to be like it is today and all the credit for not having brain metastesis of her brain, she is doing fantastic... Seh believes alive today because of CytroDyn shareholders... hers is not the only testimony or indication that lives are being saved because of Leronlimab...
Our mission is to save humanity from a powerful plague... had thought BLA filing would be the greatest news but it is not... the fight against covid-19 is:
Blood samples of first 10 patients at Montefiore revealed exciting news... without Dr. Dr. Harish Seethamraju none of these discoveries would have been possible. And Dr. Patterson's tireles work in saving lives... The value one man has brought to us in Dr. Kelly - pushed all the indications of Leronlimab forward.
I went through a lot of challenges in the past eight years and it's thanks to Dr. Kelly still here and it is possible to be here.
CytoDyn has signed agreement with ... out in the next few days and weeks.
As of this morning Dr. Patterson believes he has found several matters
Dr. Patterson:
Pleasure to be able to reveal what we've discovered and how that could potentially help with this horrible pandemic - get people back to work and save patient lives. Covid-19 is a Rantes disease.
RANTES is of broad clinical importance in an array of human diseases including AIDS, cancer, atherosclerosis, asthma, transplantation, and autoimmune diseases such as arthritis, diabetes and glomerulonephritis;6 Box 1 lists a variety of renal diseases in which expression of RANTES is involved.
First to report quantified virus in the plasma... responsible for reduction in plasma in virus... restore immune system and decrease the viral factor in patients. Cautionary... have to be concerned about our blood supply. Dramatic, exciting and unreported findings.
Lalezari:
Great relief to be able to speak plainly and simply now... not being able to share findings has been agonizing.... My focus with CytoDyn now is three things:
1. Would like to see compassionate use access for ICU and medical professionals - clear this drug is working well
2. Hoping manufacturing is ramped up quickly
3. On 3/20 wrote FDA suggesting compassionate use instead of EIND... based on ICU patients being extubated in 48 hours. Wrote FDA again on 3/27 but they said no.... then key was 4/8 when wrote back to FDA again and now knew Rantes behind the diseases... great luck for CytoDyn and all of humanity being driven by Rantes... last time asked FDA and now coming through EINDs ... no doubt in my mind at all about how important Leronlimab will be.
Pourhassan: Vyrologix
Fundraising... will not raise large funds at .30 because believe will get to a much higher level. Today I am still thinking the same... we are way undervalued. We will update very soon how we're going forward with our fundraising.
Dr. Pourhassan: three matters - BLA, Cancer, Covid-19
Four reasons or pushbacks against getting BLA completed with submission... The BLA IS submitted!
Cancer studies: 12 paitents ended up having 0 CTC after treatment... while most could not give blood samples in the last few months because of covid-19... my own family member has seen great results Her doctor never imagined her situation to be like it is today and all the credit for not having brain metastesis of her brain, she is doing fantastic... Seh believes alive today because of CytroDyn shareholders... hers is not the only testimony or indication that lives are being saved because of Leronlimab...
Our mission is to save humanity from a powerful plague... had thought BLA filing would be the greatest news but it is not... the fight against covid-19 is:
Blood samples of first 10 patients at Montefiore revealed exciting news... without Dr. Dr. Harish Seethamraju none of these discoveries would have been possible. And Dr. Patterson's tireles work in saving lives... The value one man has brought to us in Dr. Kelly - pushed all the indications of Leronlimab forward.
I went through a lot of challenges in the past eight years and it's thanks to Dr. Kelly still here and it is possible to be here.
CytoDyn has signed agreement with ... out in the next few days and weeks.
As of this morning Dr. Patterson believes he has found several matters
Dr. Patterson:
Pleasure to be able to reveal what we've discovered and how that could potentially help with this horrible pandemic - get people back to work and save patient lives. Covid-19 is a Rantes disease.
RANTES is of broad clinical importance in an array of human diseases including AIDS, cancer, atherosclerosis, asthma, transplantation, and autoimmune diseases such as arthritis, diabetes and glomerulonephritis;6 Box 1 lists a variety of renal diseases in which expression of RANTES is involved.
First to report quantified virus in the plasma... responsible for reduction in plasma in virus... restore immune system and decrease the viral factor in patients. Cautionary... have to be concerned about our blood supply. Dramatic, exciting and unreported findings.
Lalezari:
Great relief to be able to speak plainly and simply now... not being able to share findings has been agonizing.... My focus with CytoDyn now is three things:
1. Would like to see compassionate use access for ICU and medical professionals - clear this drug is working well
2. Hoping manufacturing is ramped up quickly
3. On 3/20 wrote FDA suggesting compassionate use instead of EIND... based on ICU patients being extubated in 48 hours. Wrote FDA again on 3/27 but they said no.... then key was 4/8 when wrote back to FDA again and now knew Rantes behind the diseases... great luck for CytoDyn and all of humanity being driven by Rantes... last time asked FDA and now coming through EINDs ... no doubt in my mind at all about how important Leronlimab will be.
Pourhassan: Vyrologix
Fundraising... will not raise large funds at .30 because believe will get to a much higher level. Today I am still thinking the same... we are way undervalued. We will update very soon how we're going forward with our fundraising.
9
